dc.contributor.author | Gül, Murat | |
dc.contributor.author | Şerefoğlu, Ege Can | |
dc.date.accessioned | 2019-12-23T05:49:42Z | |
dc.date.available | 2019-12-23T05:49:42Z | |
dc.date.issued | 2019 | en_US |
dc.identifier.citation | Gül, M. ve Şerefoğlu, E. C. (2019). Oxytocin antagonists: The next frontier in PE treatment. Nature Reviews Urology, 16(12), 696-697. https://doi.org/10.1038/s41585-019-0238-7 | en_US |
dc.identifier.issn | 1759-4812 | |
dc.identifier.issn | 1759-4820 | |
dc.identifier.uri | https://doi.org/10.1038/s41585-019-0238-7 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/4587 | |
dc.description.abstract | Oxytocin antagonists seem to have potential as a treatment option for premature ejaculation (PE), but the parameters of their use are vague. Two recently published studies highlight the need for large-scale trials to elucidate the value of these drugs in the treatment of PE. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Nature Publishing Group | en_US |
dc.rights | info:eu-repo/semantics/embargoedAccess | en_US |
dc.subject | Intravaginal Ejaculatory Latency | en_US |
dc.subject | Premature Ejaculation | en_US |
dc.subject | Double-Blind | en_US |
dc.subject | Receptor Antagonist | en_US |
dc.subject | Men | en_US |
dc.subject | Cligosiban | en_US |
dc.subject | Efficacy | en_US |
dc.subject | Safety | en_US |
dc.title | Oxytocin antagonists: The next frontier in PE treatment | en_US |
dc.type | editorial | en_US |
dc.relation.ispartof | Nature Reviews Urology | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Histoloji ve Embriyoloji Ana Bilim Dalı | en_US |
dc.authorid | 0000-0002-2530-7012 | en_US |
dc.identifier.volume | 16 | en_US |
dc.identifier.issue | 12 | en_US |
dc.identifier.startpage | 696 | en_US |
dc.identifier.endpage | 697 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası - Editör Denetimli Dergi | en_US |
dc.identifier.doi | 10.1038/s41585-019-0238-7 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.identifier.scopusquality | Q1 | en_US |